|
SLC6A6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.038520E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.383870E-02 |
| Normal-vs-Stage2 |
1.150370E-01 |
| Normal-vs-Stage3 |
4.917200E-01 |
| Normal-vs-Stage4 |
4.109600E-01 |
| Stage1-vs-Stage2 |
5.880800E-01 |
| Stage1-vs-Stage3 |
4.440400E-01 |
| Stage1-vs-Stage4 |
9.911200E-01 |
| Stage2-vs-Stage3 |
3.471600E-01 |
| Stage2-vs-Stage4 |
7.524400E-01 |
| Stage3-vs-Stage4 |
6.744800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.967000E-04 |
| Normal-vs-AfricanAmerican |
4.775600E-01 |
| Normal-vs-Asian |
7.013000E-01 |
| Caucasian-vs-AfricanAmerican |
6.441600E-02 |
| Caucasian-vs-Asian |
4.938000E-01 |
| AfricanAmerican-vs-Asian |
9.672800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.402100E-03 |
| Normal-vs-Female |
2.519300E-03 |
| Male-vs-Female |
1.622390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.125400E-01 |
| Normal-vs-Extreme_Weight |
1.484020E-01 |
| Normal-vs-Obese |
4.185900E-02 |
| Normal-vs-Extreme_Obese |
4.030200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.756400E-01 |
| Normal_Weight-vs-Obese |
6.720400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.455800E-01 |
| Extreme_Weight-vs-Obese |
3.747600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.506600E-01 |
| Obese-vs-Extreme_Obese |
9.652400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.852100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.296850E-03 |
| Normal-vs-Age(61-80Yrs) |
1.435980E-02 |
| Normal-vs-Age(81-100Yrs) |
8.901200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.193000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.661600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.582760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.362400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.380810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.569200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.758350E-04 |
| Normal-VS-Type2 PRCC |
9.509400E-01 |
| Normal-VS-KIRP CIMP |
2.199800E-02 |
| Normal-VS-Unclassified PRCC |
1.612250E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.201090E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.732610E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.482600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.242700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.461300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.829400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.321990E-01 |
| Normal-vs-N1 |
5.096600E-01 |
| Normal-vs-N2 |
5.129800E-01 |
| N0-vs-N1 |
4.754800E-01 |
| N0-vs-N2 |
5.007400E-01 |
| N1-vs-N2 |
5.862200E-01 |
|
|
